Anti-synthetase syndrome occurring after SARS-CoV-2 infection
Scand J Rheumatol
.
2022 May;51(3):255-257.
doi: 10.1080/03009742.2021.2024019.
Epub 2022 Feb 9.
Authors
M Bouchard Marmen
1
,
B Ellezam
2
,
M J Fritzler
3
,
Y Troyanov
4
,
P V Gould
5
,
M Satoh
6
,
A Meyer
7
,
Z Mahjoub
8
,
O Landon-Cardinal
9
Affiliations
1
Division of Rheumatology, CHU de Québec-Université Laval, Québec, Québec, Canada.
2
Division of Pathology, CHU Sainte-Justine, Université de Montréal, Montréal, Québec, Canada.
3
Cumming School of Medicine, University of Calgary, Calgary, Canada.
4
Division of Rheumatology, Department of Medicine, Hôpital du Sacré-Coeur de Montréal, Montréal, Québec, Canada.
5
Anatomic Pathology Service, Hôpital de l'Enfant-Jésus, CHU de Québec-Université Laval, Québec, Québec, Canada.
6
Department of Clinical Nursing, University of Occupational and Environmental Health, Kitakyushu, Japan.
7
Department of Physiology and Functional Explorations, University Hospital of Strasbourg, Strasbourg, France.
8
Division of Rheumatology, CISSS Chaudière-Appalaches, Université Laval, Québec, Québec, Canada.
9
Division of Rheumatology, Centre Hospitalier de l'Université de Montréal (CHUM), CHUM Research Center, Department of Medicine, Université de Montréal, Montréal, Québec, Canada.
PMID:
35138215
DOI:
10.1080/03009742.2021.2024019
No abstract available
Publication types
Letter
MeSH terms
Antibodies, Viral
COVID-19* / complications
Humans
Immunoglobulin G
Ligases
SARS-CoV-2
Substances
Antibodies, Viral
Immunoglobulin G
Ligases